Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase δ syndrome

Clin Immunol. 2016 Oct:171:38-40. doi: 10.1016/j.clim.2016.07.017. Epub 2016 Jul 19.
No abstract available

Keywords: Activated phosphoinositide 3-kinase δ syndrome; Autoimmune hemolytic anemia; Sirolimus.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Class I Phosphatidylinositol 3-Kinases
  • Humans
  • Immunologic Deficiency Syndromes / drug therapy*
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Primary Immunodeficiency Diseases
  • Sirolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Class I Phosphatidylinositol 3-Kinases
  • Sirolimus

Supplementary concepts

  • Activated PI3K-delta Syndrome